Standigm and Institut Pasteur Korea Collaborate for AI-Based Study

Standigm, a prominent workflow artificial intelligence (AI) drug discovery company, recently signed a Memorandum of Understanding (MOU) with Institut Pasteur Korea (IPK), the infectious disease-focused research organization contributing to public health, for AI-based drug discovery study for infectious disease.

Related Keywords

South Korea ,Alex Smith ,Jinhan Kim ,Youngmee Jee ,Fund Technical Accelerator Award ,Research Investment For Global Health Technology Fund ,Ministry Of Health ,Melinda Gates Foundation ,Bethan Daviesdec ,Institut Pasteur Korea ,Institut Pasteur Korea Collaborate ,Based Study ,Image Credit ,Research Investment ,Global Health Technology Fund ,